Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

David D. W. Twa(BC Cancer Agency), Fong Chun Chan(BC Cancer Agency), Susana Ben‐Neriah(BC Cancer Agency), Bruce W. Woolcock(BC Cancer Agency), Anja Mottok(BC Cancer Agency), King Tan(BC Cancer Agency), Graham W. Slack(BC Cancer Agency), Jay Gunawardana(BC Cancer Agency), Raymond S. Lim(BC Cancer Agency), Andrew McPherson(University of British Columbia), Robert Kridel(BC Cancer Agency), Adèle Telenius(BC Cancer Agency), David W. Scott(BC Cancer Agency), Kerry J. Savage(BC Cancer Agency), Sohrab P. Shah(Emory University Hospital), Randy D. Gascoyne(BC Cancer Agency), Christian Steidl(BC Cancer Agency)
Blood
February 5, 2014
Cited by 297

Abstract

The pathogenesis of primary mediastinal large B-cell lymphoma (PMBCL) is incompletely understood. Recently, specific genotypic and phenotypic features have been linked to tumor cell immune escape mechanisms in PMBCL. We studied 571 B-cell lymphomas with a focus on PMBCL. Using fluorescence in situ hybridization here, we report that the programmed death ligand (PDL) locus (9p24.1) is frequently and specifically rearranged in PMBCL (20%) as compared with diffuse large B-cell lymphoma, follicular lymphoma, and Hodgkin lymphoma. Rearrangement was significantly correlated with overexpression of PDL transcripts. Utilizing high-throughput sequencing techniques, we characterized novel translocations and chimeric fusion transcripts involving PDLs at base-pair resolution. Our data suggest that recurrent genomic rearrangement events underlie an immune privilege phenotype in a subset of B-cell lymphomas.


Related Papers

No related papers found

Powered by citation graph analysis